ERY-MET

N/A

Report date: 2025/01/26 17:00:23

Base Information

Drug NameERY-MET
Drug Alias NameerymethionaseMethionine Gamma Lyase (ERYtech)Methionine Gamma Lyase (PHAXIAM Therapeutics)ERY-MET
ClassificationBiologics > Protein drugs > EnzymeCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionLyases stimulants
TargetsLyases
Therapy Area/IndicationsSolid tumoursHomocystinuriaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesPhaxiam Therapeutics SA
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsHomocystinuriaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A